Legislators
Bills
Statements
Lobbying
Travel
- Bills
- S.1522
S.1522: A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable.
About This Bill
- Introduced May 10, 2023
- Latest Major Action May 10, 2023
Bill Sponsor
Bill Version
- Introduced in Senate - May 10, 2023
Bill Actions
Date | Description |
---|---|
May 10, 2023 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
May 10, 2023 |
Introduced in the Senate by Roger Marshall (R-Kan.) |